Cargando…
High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
Autores principales: | Lionello, Federico, Guarnieri, Gabriella, Arcaro, Giovanna, Vianello, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647974/ https://www.ncbi.nlm.nih.gov/pubmed/38028672 http://dx.doi.org/10.1002/hsr2.1685 |
Ejemplares similares
-
The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study
por: Lionello, Federico, et al.
Publicado: (2023) -
Prone Positioning Is Safe and May Reduce the Rate of Intubation in Selected COVID-19 Patients Receiving High-Flow Nasal Oxygen Therapy
por: Vianello, Andrea, et al.
Publicado: (2021) -
High-Flow Nasal Oxygen and Noninvasive Ventilation for COVID-19
por: Al-Dorzi, Hasan M., et al.
Publicado: (2022) -
High-flow nasal oxygen versus noninvasive ventilation for hypoxemic respiratory failure: Do we know enough?
por: Spoletini, Giulia, et al.
Publicado: (2016) -
Analysis of the Effects of Humidified High Flow Nasal Oxygen Therapy Combined with Noninvasive Mechanical Ventilation on Treatment Outcomes
por: Wang, Hongjun, et al.
Publicado: (2022)